Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | GPR3 | P46089 | 1/20 | 0.31 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.30 |
| ▸ | RAC2 | P15153 | 1/20 | 0.30 |
| ▸ | RAC3 | P60763 | 1/20 | 0.30 |
| ▸ | CDC42 | P60953 | 1/20 | 0.30 |
| ▸ | RAC1 | P63000 | 1/20 | 0.30 |
| ▸ | RPA1 | P27694 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22352288 | 0.97 | KDM4E (0.33) | KDM4EATML3MBTL1ALDH1A1MAPT | |
| SCHEMBL22352475 | 0.96 | KDM4E (0.34) | KDM4EATML3MBTL1ALDH1A1MAPT | |
| SCHEMBL22250397 | 0.94 | KDM4E (0.38) | KDM4EATML3MBTL1ALDH1A1MAPT | |
| SCHEMBL22250071 | 0.94 | ATM (0.40) | KDM4EATML3MBTL1ALDH1A1MAPT | |
| SCHEMBL24264569 | 0.94 | ATM (0.38) | KDM4EATML3MBTL1ALDH1A1MAPT | |
| SCHEMBL25965665 | 0.93 | ATM (0.42) | KDM4EATML3MBTL1ALDH1A1MAPT | |
| SCHEMBL22352270 | 0.93 | L3MBTL1 (0.42) | KDM4EATML3MBTL1ALDH1A1MAPT | |
| SCHEMBL10014593 | 0.93 | ATM (0.41) | KDM4EATML3MBTL1ALDH1A1MAPT | |
| SCHEMBL15785872 | 0.93 | RAC2 (0.33) | KDM4EATML3MBTL1ALDH1A1MAPT | |
| SCHEMBL15785873 | 0.93 | RAC2 (0.33) | KDM4EATML3MBTL1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11515484-B2 | Heterocyclic compound and organic light emitting element comprising same | LT MATERIALS CO., LTD. (KR) | 2022-11-29 | — | — | US | disclosed |
| US-20200266355-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | HEESUNG MATERIAL LTD. (KR) | 2020-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11515484-B2 | Heterocyclic compound and organic light emitting element comprising same | CRY1, CRY2, CYP1A1 | KDM4E 2341/4885ATM 2995/4885L3MBTL1 1142/4885 |
| US-20200266355-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, CYP1A1 | KDM4E 2341/4885ATM 2995/4885L3MBTL1 1142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.